|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
Laboratory Report
|
|
|
|||||||||||||||||||||||||
Hematology
| Test | 01-OCT-2017 | Reference Range | Unit |
|---|---|---|---|
| Leukocytes [#/volume] in Blood by Automated count | 8.4 | 4.5 - 11.0 | 10*3/uL |
| Erythrocytes [#/volume] in Blood by Automated count | 4.8 | 3.8 - 5.2 | 10*6/uL |
| Hemoglobin [Mass/volume] in Blood | 16.4 H | 12 - 16 | g/dL |
| Hematocrit [Volume Fraction] of Blood by Automated count | 40.0 | 36 - 46 | % |
| MCV [Entitic mean volume] in Red Blood Cells by Automated count | 94.2 | 80 - 100 | fL |
| MCH [Entitic mass] by Automated count | 32.3 | 27 - 33 | pg |
| MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count | 32.5 | 32 - 36 | g/dL |
| Erythrocyte [DistWidth] in Blood by Automated count | 14.4 | 11.5 - 14.5 | % |
| Platelets [#/volume] in Blood by Automated count | 188.8 | 150 - 450 | 10*3/uL |
Chemistry
| Test | 01-OCT-2017 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Serum or Plasma | 73.2 | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Serum or Plasma | 9.9 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Serum or Plasma | 2.9 H | 0.5 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Serum or Plasma | 8.7 | 8.6 - 10.3 | mg/dL |
| Sodium [Moles/volume] in Serum or Plasma | 137.0 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Serum or Plasma | 4.0 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Serum or Plasma | 105.3 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 20.7 L | 22 - 29 | mmol/L |
| Protein [Mass/volume] in Serum or Plasma | 8.2 | 6.6 - 8.3 | g/dL |
| Albumin [Mass/volume] in Serum or Plasma | 4.6 | 3.5 - 5.5 | g/dL |
| Bilirubin.total [Mass/volume] in Serum or Plasma | 12.5 H | 0.2 - 1.2 | mg/dL |
| Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 70.5 | 32 - 91 | U/L |
| Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 37.2 | 7 - 56 | U/L |
| Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 25.8 | 10 - 40 | U/L |
| Magnesium [Mass/volume] in Serum or Plasma | 1.8 | 1.7 - 2.2 | mg/dL |
| Phosphate [Mass/volume] in Serum or Plasma | 3.4 | 2.5 - 4.5 | mg/dL |
| pH of Arterial blood | 6.9 L | 7.35 - 7.45 | [pH] |
| Carbon dioxide [Partial pressure] in Arterial blood | 41.4 | 35 - 45 | mm[Hg] |
| Oxygen [Partial pressure] in Arterial blood | 96.4 | 80 - 100 | mm[Hg] |
| Bicarbonate [Moles/volume] in Arterial blood | 25.0 | 22 - 32 | mmol/L |
| Oxygen saturation in Arterial blood | 95.0 | 95 - 100 | % |
| Cholesterol [Mass/volume] in Serum or Plasma | 184.4 | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 148.1 | 0 - 149 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 102.9 H | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 51.9 | 40 - 60 | mg/dL |
Coagulation
| Test | 01-OCT-2017 | Reference Range | Unit |
|---|---|---|---|
| Prothrombin time (PT) | 9.5 L | 11.0 - 13.5 | s |
| INR in Platelet poor plasma by Coagulation assay | 1.0 | 0.9 - 1.1 | {INR} |
| aPTT in Blood by Coagulation assay | 26.4 | 22.0 - 32.0 | s |
Annotation
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows marked hyperbilirubinemia and elevated creatinine, indicating significant liver dysfunction and renal impairment. Severe acidemia (pH 6.9) and low total CO₂ suggest metabolic acidosis. Hemoglobin is mildly elevated, and LDL cholesterol is slightly high. Other parameters are within normal limits. Immediate clinical evaluation is recommended due to life-threatening acid-base disturbance and multi-organ dysfunction. |